Nyctea Technologies, a Swedish startup, is developing a smart material that promises to significantly improve the purification of biological drugs, offering higher yields and faster cycles while reducing the amount of energy needed and the use of chemicals, plastics and water. It is one of 70 young companies in AstraZeneca’s BioVenture Hub.
“Our goal is to help AstraZeneca and the pharmaceutical industry as a whole to be not just greener but more efficient and use less resources,” says co-founder and CEO Gustav Ferrand-Drake del Castillo.
To read this article and gain access to over 1000 stories about the global tech sector become a paying subscriber to The Innovator. Click here to sign up.
